---
title: Hemocompatibility and Biophysical Interface of Left Ventricular Assist Devices
  and Total Artificial Hearts
date: '2023-10-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37890145/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231028180731&v=2.17.9.post6+86293ac
source: Blood
description: Over the past two decades, there has been a significant increase in the
  utilization of long-term mechanical circulatory support (MCS) for the treatment
  of cardiac failure. Left ventricular assist devices (LVADs) and total artificial
  hearts (TAHs) have been developed in parallel to serve as bridge-to-transplant and
  destination therapy solutions. Despite the distinct hemodynamic characteristics
  introduced by LVADs and TAHs, a comparative evaluation of these devices regarding
  ...
disable_comments: true
---
Over the past two decades, there has been a significant increase in the utilization of long-term mechanical circulatory support (MCS) for the treatment of cardiac failure. Left ventricular assist devices (LVADs) and total artificial hearts (TAHs) have been developed in parallel to serve as bridge-to-transplant and destination therapy solutions. Despite the distinct hemodynamic characteristics introduced by LVADs and TAHs, a comparative evaluation of these devices regarding ...